Partner Headlines - CVS

  1. Ulta Beauty's Earnings Growth Keeps Getting Prettier

    IBD
  2. Expectations Stacked High On Costco's Q3 Earnings

    GuruFocus
  3. CVS Eyeing Omnicare Acquisition To Bolster Market Position

    GuruFocus
  4. Making Money With Charles Payne: 05/22/15

    FoxBusiness
  5. CVS To Buy Out Omnicare For $10.4 Billion

    GuruFocus
  6. Horizon Pharma Up On Bullish Leerink Initiation

    IBD
  7. Benzinga's M&A Chatter for Thursday May 21, 2015

    Benzinga
  8. CVS Confirms Omnicare Buy

    IBD
  9. Glenview Capital Raises Stake In Monsanto

    GuruFocus
  10. Stocks End Higher In Light Trade; CVS Nears Buy Point

    IBD
  11. Retail And Oil Stocks Outperform In Quiet Session

    IBD
  12. Stocks Up Despite Data; Retailers Best Buy, Dollar Tree Jump

    IBD
  13. Benzinga's Volume Movers

    Benzinga
  14. Morning Market Gainers

    Benzinga
  15. CVS Health Confirms Omnicare Buy Valued At $12.7 Bil

    IBD
  16. Benzinga's Top #PreMarket Gainers

    Benzinga
  17. These Top 7 Stocks Are Making Big Moves After Hours

    IBD
  18. Most I.D. Theft is of the Local, No-Tech Variety

    FoxBusiness
  19. Compass Capital Management's Top 3 Picks During Q1

    GuruFocus
  20. Richard Pzena Makes 12 New Buys in First Quarter

    GuruFocus
  21. Which Rx Drug Plans Show Enrollment Growth, Losses?

    IBD
  22. CVS Gives Upbeat Prognosis

    IBD
  23. Stock Futures Rise, Dow Leads; LinkedIn Tanks, Syngenta Spikes

    IBD
  24. CVS Guides Q2 Up; Q1 Tops On Pharmacy Claim Volume

    IBD
  25. US Stock Futures Surge Ahead Of Economic Data

    Benzinga
  26. Keep an Eye on These 10 Stocks for May 1, 2015

    Benzinga
  27. Benzinga's M&A Chatter for Thursday April 30, 2015

    Benzinga
  28. CVS, T. Rowe Price Impacted By Baltimore Unrest

    FoxBusiness
  29. 6 Dividend Stocks Trading at a Double-Digit Discount

    GuruFocus
  30. Why CVS Health And McKesson May Be Good Stock Picks

    IBD
  31. UnitedHealth Profit Soars On ObamaCare, Optum

    IBD
  32. UnitedHealth Up After Topping Views, Raising Outlook

    IBD
  33. UnitedHealth Eyes Biggest Earnings Gain In Years

    IBD
  34. Rite Aid Posts Impressive Q4 Results But Disappointing 2016 Guidance

    GuruFocus
  35. Making Money With Charles Payne: 04/10/15

    FoxBusiness
  36. Horizon Pharma Soars On Q4 Beat, Guidance Raise

    IBD
  37. Catamaran EPS Tops, But Stock Falls On Weak Guidance

    IBD
  38. Are Retailers Best At Pleasing Customers Top Stocks?

    IBD
  39. Making Money With Charles Payne: 02/13/15

    FoxBusiness
  40. Rite Aid To Buy EnvisionRX

    IBD
  41. Rite Aid Stock Soars, Steps Up Competition With CVS

    IBD
  42. Rite Aid To Buy Pharmacy Benefits Manager EnvisionRX

    IBD
  43. CVS Passes Its Q4 Checkup

    IBD
  44. Making Money With Charles Payne: 02/10/15

    FoxBusiness
  45. CVS Health: Smoke-Less Sales Drag Less Than Expected

    IBD
  46. Stock Futures Stretch Higher; Starwood, Coca-Cola, CVS Climb

    IBD
  47. UPDATE: CVS Health Beats Q4 Views

    Benzinga
  48. Earnings Scheduled For February 10, 2015

    Benzinga
  49. Keep an Eye on These 10 Stocks for February 10, 2015

    Benzinga
  50. CVS Health Corp. To Post First Tobacco-Free Quarter On Tuesday

    Benzinga
  51. Looking Ahead of Wall Street: Coca-Cola, PepsiCo, CVS Health

    GuruFocus
  52. From Coca-Cola To Tesla, Here Are The 68 Most Important Earnings ...

    Benzinga
  53. Will CVS Report Healthy Growth In Q4 EPS And Sales?

    IBD
  54. Gilead Sciences Offering Fresh Wave Of Competition To AbbVie's ...

    GuruFocus
  55. Amazon's Payments Business Getting Traction

    IBD
  56. AmerisourceBergen Hits New High On Earnings, Outlook

    IBD
  57. Brian Sozzi Wonders: Should CVS Health Scoop Up Divested Family ...

    Benzinga
  58. Making Money With Charles Payne: 01/22/15

    FoxBusiness
  59. Has Gilead Sciences Been Able To Maintain Its Lead Run In The ...

    GuruFocus
  60. Gilead, AbbVie Hepatitis C Price Cuts Will Hit Sales

    IBD
  61. Goldman Sachs Upgrades CVS Health To Buy

    Benzinga
  62. Benzinga's Top Upgrades

    Benzinga
  63. Drug Distributors Build Strength In An Era Of Change

    IBD
  64. Aetna Sides With Gilead In Hepatitis C Drug Battle

    IBD
  65. 18 Cool Dividend Growth Large Caps For A Hot Market

    GuruFocus
  66. Fast Money Picks For January 14: GoPro, Google, CVS

    Benzinga
  67. Express Scripts Eyes New Price War: Anti-PCSK9 Drugs

    IBD
  68. Making Money With Charles Payne: 01/13/15

    FoxBusiness
  69. Weekly Insider Sells Highlight: CVS, MNST, CAG, EVHC

    GuruFocus
  70. Weekly CEO Sells Highlight: Six Flags Entertainment Corp, Gilead ...

    GuruFocus
  71. AbbVie Stock Down After Guidance, Downgrade

    IBD
  72. Oakmark Equity and Income Fund Fourth Quarter 2014 Commentary

    GuruFocus
  73. Cramer's Top Picks In The Retail Space

    Benzinga
  74. Gilead Strikes Deal with CVS, Hits Back AbbVie

    GuruFocus
  75. Walgreen Year-End Sales Jump On Flu Prescriptions

    IBD
  76. Top 4 NYSE Stocks In The Health Care Plans Industry With The ...

    Benzinga
  77. Hepatitis Drugs Vie For Share

    IBD
  78. CVS Covering Gilead HCV Drugs, Countering AbbVie

    IBD
  79. Stocks Lose More Ground; Gilead Sciences Rises

    IBD
  80. CVS Picks Gilead Hep C Drugs As Price War Looms

    IBD
  81. Gilead Sciences Spikes Amid CVS Formulary Status

    Benzinga
  82. UPDATE: Bank Of America Raises PT On CVS Health On Competitive ...

    Benzinga
  83. Apple Pay Expansion Continues In 2015

    Benzinga
  84. Dividends To Hit Record High, But Firms Remain Wary

    IBD
  85. Walgreen Q1 Earnings Top On Strong Prescription Sales

    IBD
  86. Fast Money Picks For December 23: Gilead Sciences, Starbucks, ...

    Benzinga
  87. Bank Of America Raises CVS Health Price Target

    Benzinga
  88. Barron's Recap: Oil Stocks To Buy Now

    Benzinga
  89. Walgreen Earnings Due Amid Merger, Management Shakeup

    IBD
  90. AbbVie's Hep C Regimen OK'd, 12-Week Cost $83,319

    IBD
  91. Why Ballard Power Systems Is a Smart Investment

    GuruFocus
  92. SunTrust Presents Possible Pair Trade With Walgreen, CVS Heath

    Benzinga
  93. Benzinga's Top Upgrades

    Benzinga
  94. SunTrust Robinson Humphrey Upgrades CVS Health To Buy

    Benzinga
  95. Rite Aid Soars On Q3 Earnings, Raised Guidance

    IBD
  96. Dividend, Buybacks Lift CVS

    IBD
  97. Stocks Close Near Lows After Volatile Session

    IBD
  98. Stocks Rebound Strongly; Monster, Alibaba Rally

    IBD
  99. CVS Shares Up On Guidance, Dividend, Share Buyback

    IBD
  100. Top Performing Industries For December 16, 2014

    Benzinga
Trading Center